NDC 65250-003

Zilretta

Triamcinolone Acetonide Extended-release Injectable Suspension

Zilretta is a Intra-articular Kit in the Human Prescription Drug category. It is labeled and distributed by Pacira Pharmaceuticals, Inc.. The primary component is .

• Product ID: 65250-003_194ea571-09be-4abe-bc77-a154faba243f
• NDC: 65250-003
• Product Type: Human Prescription Drug
• Proprietary Name: Zilretta
• Generic Name: Triamcinolone Acetonide Extended-release Injectable Suspension
• Dosage Form: Kit
• Route of Administration: INTRA-ARTICULAR
• Marketing Start Date: 2017-10-06
• Marketing Category: NDA /
• Application Number: NDA208845
• Labeler Name: Pacira Pharmaceuticals, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 65250-003-01

1 KIT in 1 CARTON (65250-003-01) * 1 INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE in 1 VIAL, SINGLE-DOSE (65250-001-01) * 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE (65250-002-01)

• Marketing Start Date: 2017-10-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Zilretta" or generic name "Triamcinolone Acetonide Extended-release Injectable Suspension"

NDC	Brand Name	Generic Name
65250-003	Zilretta	triamcinolone acetonide extended-release injectable suspension
70801-003	Zilretta	triamcinolone acetonide extended-release injectable suspension